Radiology Business October 20, 2023
Radiology has experienced the steadiest increase of artificial intelligence/machine learning-enabled device submissions of any specialty, the U.S. Food and Drug Administration reported Thursday.
Through the end of July, 79% of all AI products authorized by the agency in 2023 are in radiology (85 products), followed by 9% in cardiovascular care (10), 5% in neurology (5), 4% in gastroenterology/urology (4) and 2% in anesthesiology (2).
“Interest in medical devices incorporating AI/ML functionality has increased in recent years and even more so in recent months due to the development of large language models,” the agency said Oct. 19, pointing to products such as ChatGPT, Llama, Claude and PaLM.
Based on projected volume in 2023, the increase of AI-powered devices is expected to...
Today's Sponsors
Today's Sponsor